Novartis Investigative Site

Provo, Utah 84604

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Multiple Sclerosis

Studies at this site

• Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies — Completed
• Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone — Stopped early